|
|
Presentation Number: |
H-1137a |
Abstract Title: |
RESIST-1: A phase 3, randomized, controlled, open-label, multicenter trial comparing tipranavir/ritonavir (TPV/r) to an optimized comparator protease inhibitor/r (CPI/r) regimen in antiretroviral (ARV) experienced patients: 24-week data. |
Presentation Start/End Time: |
Sunday, Oct 31, 2004, 4:00 PM - 4:10 PM |
Author Block: |
C. HICKS;
Duke University Medical Center, Durham, NC. |
Topic: |
H |
Keywords: |
antiretroviral,tipranavir,protease inhibitor |
Commercial Relationship: |
C. Hicks, None. |
| |
|
|
|
|
|
|
The Online Abstract Submission and Invitation System
© 1996 - 2010 Coe-Truman Technologies, Inc. All rights reserved.
|
|
|
|
|
